Optimus Healthcare Services, Inc. 8-K

What Happened

• Optimus Healthcare Services, Inc. announced on July 14, 2026 that, with unanimous Board approval, it entered a Wind-Down and Distribution Agreement with its first-priority secured lender (the Agent and Purchasers) to settle outstanding secured debt of $4.4 million plus accrued interest on its convertible notes.
• Under the agreement the Company will deliver its remaining cash (after paying necessary wind‑down operating expenses) to the Agent. Upon final payment on or about July 31, 2026, the Agent and Purchasers will deem the Notes terminated and will release the Company and its officers and directors.
• After the final payment, the Company’s operations will cease and its bank accounts will be closed. All of the Company’s directors and officers will resign effective August 5, 2026.
• Background: the Board completed a strategic review (announced Sept 11, 2025) and initiated a wind‑down due to lack of alternatives and inability to cure Specified Defaults under its May 2021 and June 2022 Notes. Earlier, on April 14, 2025 the Company entered a fourth amendment to a Forbearance Agreement that extended certain deadlines to April 30, 2025 and adjusted registration‑filing timing.

Key Details

• Debt settlement: $4.4 million plus accrued interest (agreement dated July 14, 2026).
• Final payment and Notes termination targeted on or about July 31, 2026.
• Corporate actions: operations to cease and bank accounts to close after final payment; D&O resignations effective August 5, 2026.
• Prior wind‑down actions: Board-approved reduction in force; Company maintained a core team to manage regulatory patient transitions and asset‑maximization; Company paid in full a secured JP Morgan Chase loan in connection with the wind‑down.

Why It Matters

• The filing documents an orderly wind‑down and a secured‑debt settlement that will end the Company’s operating activities. For investors, this is a material corporate event: the company will stop operating, deliver remaining cash to its secured lender, and its senior leadership will resign. These actions will have direct implications for the company’s future operations and any residual value available to creditors or shareholders.